Karl Utermohlen

Karl Utermohlen

Recent Articles

Bed Bath & Beyond Inc. (BBBY) Stock Sinks After Disappointing Q3

Bed Bath & Beyond Inc. (BBBY) shares were slipping Thursday as the company reported disappointing third-quarter results. Here's what you should know.

Uber Forced to Pull Self-Driving Cars Off California Roads

Uber has remove its self-driving cars off California roads because the company did not follow proper procedure to deploy these cars in the road.

Why GoPro Inc (GPRO) Stock Is Spiking Today

GoPro Inc (GPRO) shares are on the rise Thursday as rumors of a potential company takeover are making the rounds. Here's what you should know.

3 Stocks to Watch on Wednesday: FedEx Corporation (FDX), Steelcase Inc. (SCS) and Nike Inc (NKE)

FedEx (FDX) and Steelcase (SCS) both reported earnings that sent these stocks down, while Nike topped earnings, sending NKE shares higher.

Jarvis: 9 Things to Know About Mark Zuckerberg’s AI Butler

Jarvis is the name of Facebook creator Mark Zuckerberg's new AI creation, which serves as a butler, complying with your every need (just about).

6 Retailers Including Disney Agree to Ditch On-Call Scheduling

Six retailers have agreed to ditch on-call scheduling, including Disney. Here's what you should know about the move, which is a result of unfair practices.

Rock and Roll Hall of Fame Inductees for 2017: Tupac, Pearl Jam, More

The 2017 Rock and Roll Hall of Fame list of inductees has been announced and it will include the likes of Pearl Jam, Tupac, Yes and others.

U.S. Facing Whipped Cream Shortage Ahead of Holidays

There is a whipped cream shortage in the U.S. as an Airgas explosion at an Airgas Inc facility in Florida led to a shortage of nitrous oxide.

CarMax, Inc Q3 Earnings: Why KMX Is Higher Today

CarMax, Inc shares were popping as the company reported its latest quarterly earnings results, which topped expectations for profit, while sales disappointed.

3 Stocks to Watch on Tuesday: Biogen Inc (BIIB), Conatus Pharmaceuticals Inc (CNAT) and General Motors Company (GM)

Biogen (BIIB) announced a major management change, Conatus (CNAT) inked a liver drug deal with Novartis and GM (GM) slows sedan production.